POS-391 Human Phospholipase A2 Receptor 1 antibodies from patients with active disease induce membranous nephropathy in minipigs

Bibliographic Details
Main Author:	L. Reinhard
Format:	Article
Language:	English
Published:	Elsevier 2021-04-01
Series:	Kidney International Reports
Online Access:	http://www.sciencedirect.com/science/article/pii/S2468024921005556

Anti-phospholipase A2 receptor antibodies in membranous nephropathy
by: Sangho Lee
Published: (2018-09-01)

The significance of anti-phospholipase receptor antibodies in a patient with membranous nephropathy
by: Jayaprakash R Dasari, et al.
Published: (2020-01-01)

Current Concepts on Anti-Phospholipase A2 Receptor Antibody in Idiopathic Membranous Nephropathy
by: Hamid Nasri
Published: (2014-04-01)

Anti-phospholipase A2 receptor antibody in idiopathic membranous nephropathy: New concepts
by: Mohammad-Reza Ardalan, et al.
Published: (2013-01-01)

Significance of anti-phospholipase A2 receptor antibodies in membranous nephropathy after renal transplantation
by: Praveen Kumar Etta, et al.
Published: (2020-01-01)

Role of phospholipase A2 receptor 1 antibody level at diagnosis for long-term renal outcome in membranous nephropathy.
by: Maida Mahmud, et al.
Published: (2019-01-01)

Primary antiphospholipid syndrome associated with anti-phospholipase A2 receptor antibody-positive membranous nephropathy
by: Maxime Teisseyre, et al.
Published: (2020-05-01)

Anti-phospholipase A2 receptor antibody as a prognostic marker in patients with primary membranous nephropathy
by: Eun Joo Song, et al.
Published: (2018-09-01)

Analysis of predictive factors for immunosuppressive response in anti-phospholipase A2 receptor antibody positive membranous nephropathy
by: Chao Li, et al.
Published: (2018-12-01)

A case report of breast cancer and membranous nephropathy with positive anti phospholipase A2 receptor antibodies
by: David Mathew, et al.
Published: (2021-09-01)

Ischemic stroke in anti-phospholipase A2 receptor antibody-positive primary membranous nephropathy: clinical and neuroimaging characteristics
by: Jing Zhang, et al.
Published: (2020-02-01)

Retrospective study: clinicopathological features and prognosis of idiopathic membranous nephropathy with seronegative anti-phospholipase A2 receptor antibody
by: Wenkai Guo, et al.
Published: (2020-02-01)

The relationship of anti-phospholipase A2 receptor antibody and C5a complement with disease activity and short-term outcome in idiopathic membranous nephropathy
by: Jyun Ni Chi, et al.
Published: (2019-05-01)

Renal Phospholipase A2 Receptor and the Clinical Features of Idiopathic Membranous Nephropathy
by: Ning-Xin Xu, et al.
Published: (2017-01-01)

Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy.
by: Yun Jung Oh, et al.
Published: (2013-01-01)

Outcomes of primary membranous nephropathy based on serum anti-phospholipase A2 receptor antibodies and glomerular phospholipase A2 receptor antigen status: a retrospective cohort study
by: Peihong Yin, et al.
Published: (2020-01-01)

Phospholipase A2 Receptor Antibody IgG4 Subclass Improves Sensitivity and Specificity in the Diagnosis of Idiopathic Membranous Nephropathy
by: Biao Huang, et al.
Published: (2019-06-01)

Clinical usefulness of anti-M-type phospholipase-A-receptor antibodies in patients with membranous nephropathy and the comparison of three quantification methods
by: Yasuhiro Katsumata, et al.
Published: (2020-01-01)

Anti-Phospholipase A2 Receptor Antibodies in Biopsy-Proven Idiopathic Membranous Nephropathy: A Report from the Pakistani Population
by: Haneef, M., et al.
Published: (2022)

Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD
by: Nicolas Hanset, et al.
Published: (2020-03-01)

Expression of phospholipase A2 receptor and IgG4 in patients with membranous nephropathy
by: Liu L, et al.
Published: (2018-05-01)

Prevalence of serum anti M-type phospholipase A2 receptor antibody in primary membranous nephropathy: A single center experience
by: N Gopalakrishnan, et al.
Published: (2016-01-01)

Clinical features, course and prognosis of idiopathic membranous nephropathy depending on the presence of antibodies against M-type phospholipase A2 receptor
by: Elías Jatem Escalante, et al.
Published: (2015-09-01)

CD19 Targeted Low-Dose Rituximab Is Effective in the Management of Refractory Phospholipase A2 Receptor Antibody-Associated Membranous Nephropathy
by: Raja Ramachandran, et al.
Published: (2017-01-01)

The role of Anti-phospholipase A2 Receptor Autoantibody as a biomarker of Idiopathic Membranous Nephropathy
by: Rodrigo Manuel Brás Batata
Published: (2021)

Anti-Phospholipase A2 Receptor (PLA2R) Antibody and Glomerular PLA2R Expression in Japanese Patients with Membranous Nephropathy.
by: Kei Hihara, et al.
Published: (2016-01-01)

Analysis of Glomerular IgG Subclasses Switch in Idiopathic Membranous Nephropathy Classified by Glomerular Phospholipase A2 Receptor Antigen and Serum Antibody
by: Hao-yuan Cui, et al.
Published: (2021-01-01)

Serum Albumin Still of Interest to Predict Outcomes in Membranous Nephropathy in the Era of Phospholipase A2 Receptor
by: Marion Delafosse, et al.
Published: (2020-09-01)

Association of <it>phospholipase A2 receptor 1 </it>polymorphisms with idiopathic membranous nephropathy in Chinese patients in Taiwan
by: Liao Wen-Ling, et al.
Published: (2010-10-01)

Correlation and discrepancy of phospholipase A2 receptor staining in membranous nephropathy in paraffin-embedded kidney biopsies
by: Nasar Yousuf Alwahaibi, et al.
Published: (2018-01-01)

A Comprehensive Phenotypic and Functional Immune Analysis Unravels Circulating Anti–Phospholipase A2 Receptor Antibody Secreting Cells in Membranous Nephropathy Patients
by: Chiara Cantarelli, et al.
Published: (2020-10-01)

A New Chemiluminescence Immunoassay for Phospholipase A2 Receptor 1 Autoantibodies Allows Early Identification of Autoantibody Recurrence in Patients With Membranous Nephropathy
by: Elion Hoxha, et al.
Published: (2021-04-01)

Thrombotic thrombocytopenic purpura developed during the conservative treatment of anti-phospholipase A2 receptor antibody-positive idiopathic membranous nephropathy: a case report
by: Rei Iio, et al.
Published: (2020-10-01)

Relationship between renal tissues phospholipase A2 receptor and its serum antibody and clinical condition and prognosis of idiopathic membranous nephropathy: a meta-analysis
by: Dan Dong, et al.
Published: (2019-12-01)

Anti-neutrophil cytoplasmic antibody-associated glomerulonephritis with detection of myeloperoxidase and phospholipase A2 receptor in membranous nephropathy-lesions: report of two patients with microscopic polyangiitis
by: Kenta Tominaga, et al.
Published: (2018-05-01)

Circulating anti-phospholipase A2 receptor antibodies as a diagnostic and prognostic marker in Greek patients with idiopathic membranous nephropathy – a retrospective cohort study
by: Provatopoulou Simella, et al.
Published: (2019-06-01)

An anti-phospholipase A2 receptor quantitative immunoassay and epitope analysis in membranous nephropathy reveals different antigenic domains of the receptor.
by: Astrid Behnert, et al.
Published: (2013-01-01)

Ibrolipim attenuates early-stage nephropathy in diet-induced diabetic minipigs: Focus on oxidative stress and fibrogenesis
by: Yi Liu, et al.
Published: (2020-09-01)

Development of a Standardized Chemiluminescence Immunoassay for the Detection of Autoantibodies Against Human M-Type Phospholipase A2 Receptor in Primary Membranous Nephropathy
by: Cornelia Dähnrich, et al.
Published: (2020-02-01)

Retrospective Study of Phospholipase A2 Receptor and IgG Subclasses in Glomerular Deposits in Chinese Patients with Membranous Nephropathy.
by: Hong-Rui Dong, et al.
Published: (2016-01-01)

POS-391 Human Phospholipase A2 Receptor 1 antibodies from patients with active disease induce membranous nephropathy in minipigs

Similar Items

Similar Items